Skip to Content

Hikma Pharmaceuticals PLC ADR HKMPY

Morningstar Rating
$50.66 −0.87 (1.69%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

HKMPY is trading at a 278% premium.
Price
$50.67
Fair Value
$46.22
Uncertainty
High
1-Star Price
$17.60
5-Star Price
$74.30
Economic Moat
Hgg
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if HKMPY is a good fit for your portfolio.

News

Trading Information

Previous Close Price
$51.53
Day Range
$50.6552.10
52-Week Range
$42.2356.63
Bid/Ask
$49.40 / $52.73
Market Cap
$5.62 Bil
Volume/Avg
2,421 / 2,098

Key Statistics

Price/Earnings (Normalized)
10.91
Price/Sales
1.96
Dividend Yield (Trailing)
2.84%
Dividend Yield (Forward)
2.84%
Total Yield
2.84%

Company Profile

Hikma Pharmaceuticals PLC is engaged in developing, manufacturing, and marketing a broad range of generic, branded and non-branded, in-licensed pharmaceutical products. The firm operates in three segments: injectables, generics, and branded. The majority of the revenue for the company is generated from its injectables segment under which it supplies hospitals across markets with generic injectable products, supported by its manufacturing facilities. Geographically, North America is the company's key revenue generating market followed by Middle East and North Africa, United Kingdom, Europe and the rest of the world.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stock Style Box
Mid Core
Total Number of Employees
9,100

Comparables

Valuation

Metric
HKMPY
APH
ERGO
Price/Earnings (Normalized)
10.9112.6131.20
Price/Book Value
2.551.068.19
Price/Sales
1.961.214.55
Price/Cash Flow
12.636.0635.25
Price/Earnings
HKMPY
APH
ERGO

Financial Strength

Metric
HKMPY
APH
ERGO
Quick Ratio
0.821.831.72
Current Ratio
1.572.571.79
Interest Coverage
4.75−4.1330.39
Quick Ratio
HKMPY
APH
ERGO

Profitability

Metric
HKMPY
APH
ERGO
Return on Assets (Normalized)
10.72%5.13%17.36%
Return on Equity (Normalized)
22.63%10.13%28.99%
Return on Invested Capital (Normalized)
15.78%8.41%26.30%
Return on Assets
HKMPY
APH
ERGO
See how this stock stacks up to its competitors with Morningstar Investor

Drug Manufacturers - Specialty & Generic Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Merck KGaA ADR
MKKGY
HzrcwgpgzZwqxfvf$77.8 Bil
Zoetis Inc Class A
ZTS
KfhsntnrscDgnm$76.7 Bil
Haleon PLC ADR
HLN
RynsrlqtMtqj$38.2 Bil
Teva Pharmaceutical Industries Ltd ADR
TEVA
LqpxhbjtmFwxn$19.4 Bil
Viatris Inc
VTRS
SywysyytCtx$12.2 Bil
Dr Reddy's Laboratories Ltd ADR
RDY
MhpvmfzjQclqk$11.9 Bil
Catalent Inc
CTLT
MwjylrbpYjjcxq$9.9 Bil
Perrigo Co PLC
PRGO
SxwkxxgjfMzlj$3.5 Bil
Prestige Consumer Healthcare Inc
PBH
FqqmvwghWphfmdd$3.3 Bil
Curaleaf Holdings Inc
CURLF
XvwbqtzxfVzng$3.0 Bil

Sponsor Center